| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-08 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.27 | 6e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 8e-06 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |